Anti-CD38 Antibody (Daratumumab)
Catalog No.
F1370
Anti-CD38 Antibody (Daratumumab)
Featured Products
Daratumumab (Anti-Human CD38) is a first-in-class specific anti-CD38 monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effects. Daratumumab impairs the adhesion of MM cells, thereby increasing the sensitivity of MM to proteasome inhibition.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
145.26 kDa
Dry ice
945721-28-8
- 1. Hou-Long Luo, Huan Ding, Fan Chen. "Rapid identification and quantification of residual daratumumab in multiple myeloma patients by MALDI-TOF mass spectrometry." Clinica Chimica Acta Volume 581, 1 February 2026, 120775 PMID: 41360359
- 2. Hou-Long Luo, Anping Xu, et al. "Rapid identification of daratumumab interference with M-protein detection using MALDI-TOF mass spectrometry: a case study involving renal light chain amyloidosis." Pract Lab Med. 2025 Jul 15:46:e00493 PMID: 40704354
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Darzalex, Zhaoke, JNJ-54767414
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P28907
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD38 NHis at 2 ug/mL can bind Anti-CD38 Antibody (Daratumumab)
CD38
Please avoid freeze-thaw cycles.